Pancreatic Cancer Research

ResearcherGerman Cancer Research CenterActive in the last 2 years

Rienk Offringa

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0001-6310-1026; OpenAlex author ID A5011701229. Sources: OpenAlex.

Their work

Papers
11 (first author 0, last author 4)
Trials
0
Grants
0
Labs led
1
Collaborators
54
Papers, trials and grants by year

2014: 1 paper · 2015: 1 paper · 2016: 2 papers · 2017: none · 2018: none · 2019: none · 2020: 2 papers · 2021: 1 paper · 2022: none · 2023: 1 paper · 2024: none · 2025: 3 papers

Papers 11

  1. Characterization of single neurons reprogrammed by pancreatic cancer. Co-author DOI 10.1038/s41586-025-08735-3↗
  2. Enhanced mutanome analysis towards the induction of neoepitope-reactive T-cell responses for personalized immunotherapy of pancreatic cancer. Last author DOI 10.1136/jitc-2025-011802↗
  3. [Implementation of personalized T-cell therapy in the treatment of pancreatic cancer]. Co-author DOI 10.3760/cma.j.cn112139-20250328-00164↗
  4. Transcriptome-based identification of tumor-reactive and bystander CD8+ T cell receptor clonotypes in human pancreatic cancer. Last author DOI 10.1126/scitranslmed.adh9562↗
  5. Deep molecular characterization linked to drug response profiling of pancreatic ductal adenocarcinoma using patient-derived organoids Co-author DOI 10.1101/2021.08.26.457743↗
  6. The m6A-Related mRNA Signature Predicts the Prognosis of Pancreatic Cancer Patients. Co-author DOI 10.1016/j.omto.2020.04.011↗
  7. Radiation-induced alterations in immunogenicity of a murine pancreatic ductal adenocarcinoma cell line. Co-author DOI 10.1038/s41598-020-57456-2↗
  8. Identification of a tumor-reactive T-cell repertoire in the immune infiltrate of patients with resectable pancreatic ductal adenocarcinoma. Last author DOI 10.1080/2162402x.2016.1240859↗
  9. Association of genetic polymorphisms with survival of pancreatic ductal adenocarcinoma patients. Co-author DOI 10.1093/carcin/bgw080↗
  10. Phenotype, function and T cell receptor repertoire of tumor-infiltrating lymphocytes in patients with pancreatic ductal adenocarcinoma Last author DOI 10.1186/2051-1426-3-s2-p44↗
  11. Prevailing role of contact guidance in intrastromal T-cell trapping in human pancreatic cancer. Co-author DOI 10.1158/1078-0432.ccr-13-2972↗

Closest collaborators

The 25 strongest of 54 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Oliver Strobel · 6 shared papers, 2015–2025 · strength 0.59
  2. Zibo Meng · 3 shared papers, 2020–2025 · strength 0.56
  3. Isabel C. Poschke · 5 shared papers, 2014–2025 · strength 0.50
  4. Michael Volkmar · 4 shared papers, 2016–2025 · strength 0.49
  5. Martin Ronald Sprick · 3 shared papers, 2016–2025 · strength 0.43
  6. Andreas Trumpp · 3 shared papers, 2016–2025 · strength 0.43
  7. Hongsheng Wu · 1 shared paper, 2025 · strength 0.30
  8. Thilo Hackert · 3 shared papers, 2016–2025 · strength 0.26
  9. Heshui Wu · 2 shared papers, 2020–2023 · strength 0.26
  10. Carl-Stephan Leonhardt · 2 shared papers, 2021–2023 · strength 0.24
  11. Nathalia A. Giese · 3 shared papers, 2014–2021 · strength 0.18
  12. Vera Thiel · 1 shared paper, 2025 · strength 0.18
  13. John P. Neoptolemos · 1 shared paper, 2025 · strength 0.18
  14. Albrecht Stenzinger · 1 shared paper, 2025 · strength 0.18
  15. Markus Wolfgang Büchler · 2 shared papers, 2016–2021 · strength 0.14
  16. Jingyuan Zhao · 1 shared paper, 2020 · strength 0.12
  17. Xin Jin · 1 shared paper, 2020 · strength 0.12
  18. Jürgen Debus · 1 shared paper, 2020 · strength 0.11
  19. Stefan Rieken · 1 shared paper, 2020 · strength 0.11
  20. Philipp Schröter · 1 shared paper, 2020 · strength 0.11
  21. Solange Le Blanc · 1 shared paper, 2021 · strength 0.10
  22. Sebastian Schuth · 1 shared paper, 2021 · strength 0.10
  23. Anna‐Katharina König · 1 shared paper, 2021 · strength 0.10
  24. Christian Conrad · 1 shared paper, 2021 · strength 0.10
  25. Miriam Schenk · 1 shared paper, 2021 · strength 0.10

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.